IRB Approval

Att 4 Abt IRB 0853 Transgender Full Approval.pdf

Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States

IRB Approval

OMB: 0920-1091

Document [pdf]
Download: pdf | pdf
Institutional Review Board Notice of Approval

Principal Investigator/Project Director: Cynthia Klein
Project Title: CDC Transgender
Sponsor Agency: CDC
Abt IRB #:

0853

IRB Review Date:

4/14/2016

Review Type:

Expedited

IRB Approval Date:

8/9/2016

Type of approval:

Full Implementation

Please note the following requirements:
Problems or adverse reactions: If any problems in treatment of human subjects or unexpected
adverse reactions occur as a result of this study, you must notify the IRB Chairperson or IRB
Administrator immediately.
Consent forms: In the event the approved study includes procedures for written informed
consent, you only may use consent forms that bear the Abt Associates Inc. IRB approval stamp.
Renewal: You are required to apply for renewal of approval at least annually for as long as the
study is active. Your next review date should be on or before 8/8/2017.
Teresa Doksum, Ph.D., M.P.H.
IRB Chair
Abt Associates Inc.
55 Wheeler Street
Cambridge, MA 02138
[email protected]
617-349-2896
Cc: Katie Speanburg, IRB Administrator

Date: 12/6/2016


File Typeapplication/pdf
AuthorTeresa Doksum
File Modified2016-12-06
File Created2016-12-06

© 2024 OMB.report | Privacy Policy